SEACH MEDICAL GROUP LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 157.7 ILa | +3.82% |
|
+1.09% | -9.99% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 0.877 | 214.7 | 123.2 | 62.09 | 59.61 |
| Enterprise Value (EV) 1 | -25.55 | 191.2 | 115.4 | 68.5 | 72.22 |
| P/E ratio | -10.3 x | 18.7 x | 22.9 x | -18.2 x | -5.67 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 0.03 x | 5.83 x | 1.83 x | 0.46 x | 0.4 x |
| EV / Revenue | -0.89 x | 5.2 x | 1.71 x | 0.51 x | 0.48 x |
| EV / EBITDA | -4.39 x | 31 x | 17.4 x | 15.7 x | 55.9 x |
| EV / FCF | -0.57 x | -8.94 x | -10.5 x | 5.85 x | -141 x |
| FCF Yield | -177% | -11.2% | -9.57% | 17.1% | -0.71% |
| Price to Book | 5.87 x | 2.91 x | 1.44 x | 0.72 x | 0.77 x |
| Nbr of stocks (in thousands) | 100 | 31,292 | 33,979 | 34,024 | 34,024 |
| Reference price 2 | 8.770 | 6.860 | 3.625 | 1.825 | 1.752 |
| Announcement Date | 3/15/20 | 3/21/21 | 3/21/22 | 4/20/23 | 4/3/24 |
1ILS in Million2ILS
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 18.55 | 28.83 | 36.8 | 67.34 | 134.2 | 150.3 |
| EBITDA 1 | 9.499 | 5.827 | 6.159 | 6.628 | 4.354 | 1.293 |
| EBIT 1 | 9.075 | 5.084 | 4.688 | 4.404 | -0.898 | -2.365 |
| Operating Margin | 48.92% | 17.63% | 12.74% | 6.54% | -0.67% | -1.57% |
| Earnings before Tax (EBT) 1 | 10.37 | -20.99 | 13.3 | 6.232 | -4.067 | -10.28 |
| Net income 1 | 8.015 | -22.55 | 11.97 | 5.349 | -3.411 | -10.51 |
| Net margin | 43.21% | -78.22% | 32.52% | 7.94% | -2.54% | -6.99% |
| EPS 2 | 80.15 | -0.8542 | 0.3673 | 0.1584 | -0.1003 | -0.3089 |
| Free Cash Flow 1 | -2.048 | 45.22 | -21.38 | -11.04 | 11.72 | -0.5121 |
| FCF margin | -11.04% | 156.82% | -58.1% | -16.4% | 8.73% | -0.34% |
| FCF Conversion (EBITDA) | - | 776% | - | - | 269.09% | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/27/19 | 3/15/20 | 3/21/21 | 3/21/22 | 4/20/23 | 4/3/24 |
1ILS in Million2ILS
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.05 | - | - | - | 6.41 | 12.6 |
| Net Cash position 1 | - | 26.4 | 23.4 | 7.76 | - | - |
| Leverage (Debt/EBITDA) | 0.005264 x | - | - | - | 1.472 x | 9.75 x |
| Free Cash Flow 1 | -2.05 | 45.2 | -21.4 | -11 | 11.7 | -0.51 |
| ROE (net income / shareholders' equity) | 34.1% | -65.9% | 19% | 5.98% | -5.35% | -12.5% |
| ROA (Net income/ Total Assets) | 16.4% | 6.31% | 3.66% | 2.49% | -0.39% | -1.01% |
| Assets 1 | 49 | -357.2 | 327 | 215.1 | 882.5 | 1,041 |
| Book Value Per Share 2 | 217.0 | 1.490 | 2.360 | 2.530 | 2.530 | 2.280 |
| Cash Flow per Share 2 | 59.00 | 0.9100 | 0.7600 | 0.6500 | 0.6400 | 0.3000 |
| Capex 1 | 3.37 | 3.27 | 4.48 | 1.9 | 1.24 | 0.89 |
| Capex / Sales | 18.18% | 11.33% | 12.17% | 2.81% | 0.92% | 0.59% |
| Announcement Date | 5/27/19 | 3/15/20 | 3/21/21 | 3/21/22 | 4/20/23 | 4/3/24 |
1ILS in Million2ILS
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -9.99% | 14.07M | |
| +19.10% | 3.09B | |
| +24.15% | 1.85B | |
| +104.44% | 693M | |
| +6.82% | 504M | |
| +53.52% | 191M | |
| +1.67% | 98.94M | |
| -7.57% | 96.43M | |
| +42.19% | 65.43M | |
| +38.20% | 51.84M |
- Stock Market
- Equities
- SEMG Stock
- Financials Seach Medical Group Ltd